» Articles » PMID: 30699352

Persistence of Integrase-Deficient Lentiviral Vectors Correlates with the Induction of STING-Independent CD8 T Cell Responses

Overview
Journal Cell Rep
Publisher Cell Press
Date 2019 Jan 31
PMID 30699352
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Lentiviruses are among the most promising viral vectors for in vivo gene delivery. To overcome the risk of insertional mutagenesis, integrase-deficient lentiviral vectors (IDLVs) have been developed. We show here that strong and persistent specific cytotoxic T cell (CTL) responses are induced by IDLVs, which persist several months after a single injection. These responses were associated with the induction of mild and transient maturation of dendritic cells (DCs) and with the production of low levels of inflammatory cytokines and chemokines. They were independent of the IFN-I, TLR/MyD88, interferon regulatory factor (IRF), retinoic acid induced gene I (RIG-I), and stimulator of interferon genes (STING) pathways but require NF-κB signaling in CD11c DCs. Despite the lack of integration of IDLVs, the transgene persists for 3 months in the spleen and liver of IDLV-injected mice. These results demonstrate that the capacity of IDLVs to trigger persistent adaptive responses is mediated by a weak and transient innate response, along with the persistence of the vector in tissues.

Citing Articles

CRISPR technology in human diseases.

Feng Q, Li Q, Zhou H, Wang Z, Lin C, Jiang Z MedComm (2020). 2024; 5(8):e672.

PMID: 39081515 PMC: 11286548. DOI: 10.1002/mco2.672.


T-cell immunity induced and reshaped by an anti-HPV immuno-oncotherapeutic lentiviral vector.

Fert I, Douguet L, Vesin B, Moncoq F, Noirat A, Authie P NPJ Vaccines. 2024; 9(1):102.

PMID: 38858404 PMC: 11164992. DOI: 10.1038/s41541-024-00894-0.


Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies.

Zhang J, Yu S, Peng Q, Wang P, Fang L Cancer Biol Med. 2024; 21(1).

PMID: 38172538 PMC: 10875285. DOI: 10.20892/j.issn.2095-3941.2023.0440.


Focused ultrasound-mediated small-molecule delivery to potentiate immune checkpoint blockade in solid tumors.

Wu Q, Xia Y, Xiong X, Duan X, Pang X, Zhang F Front Pharmacol. 2023; 14:1169608.

PMID: 37180717 PMC: 10173311. DOI: 10.3389/fphar.2023.1169608.


Lentiviral Vectors as a Vaccine Platform against Infectious Diseases.

Nemirov K, Bourgine M, Anna F, Wei Y, Charneau P, Majlessi L Pharmaceutics. 2023; 15(3).

PMID: 36986707 PMC: 10053212. DOI: 10.3390/pharmaceutics15030846.


References
1.
Karwacz K, Mukherjee S, Apolonia L, Blundell M, Bouma G, Escors D . Nonintegrating lentivector vaccines stimulate prolonged T-cell and antibody responses and are effective in tumor therapy. J Virol. 2009; 83(7):3094-103. PMC: 2655594. DOI: 10.1128/JVI.02519-08. View

2.
Probst H, Lagnel J, Kollias G, van den Broek M . Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8+ T cell tolerance. Immunity. 2003; 18(5):713-20. DOI: 10.1016/s1074-7613(03)00120-1. View

3.
Pichlmair A, Diebold S, Gschmeissner S, Takeuchi Y, Ikeda Y, Collins M . Tubulovesicular structures within vesicular stomatitis virus G protein-pseudotyped lentiviral vector preparations carry DNA and stimulate antiviral responses via Toll-like receptor 9. J Virol. 2006; 81(2):539-47. PMC: 1797478. DOI: 10.1128/JVI.01818-06. View

4.
Swiecki M, Gilfillan S, Vermi W, Wang Y, Colonna M . Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual. Immunity. 2010; 33(6):955-66. PMC: 3588567. DOI: 10.1016/j.immuni.2010.11.020. View

5.
Apostolopoulos V, McKenzie I, Lees C, Matthaei K, Young I . A role for IL-5 in the induction of cytotoxic T lymphocytes in vivo. Eur J Immunol. 2000; 30(6):1733-9. DOI: 10.1002/1521-4141(200006)30:6<1733::AID-IMMU1733>3.0.CO;2-E. View